Experimental dual-drug nanotherapy crosses the blood–brain barrier and improves survival in preclinical glioblastoma models
A nanotechnology-based approach packages two existing cancer drugs into tiny particles engineered to cross the brain’s protective blood-brain barrier and target glioblastoma tumor cells. …










